View Cart (0)
Your cart is empty
-
Getting the medical-grade genetic testing that experts trust is now easier than ever. Learn how.
-
NEW: Sponsored genetic testing for people suspected of having familial cardiomyopathy or arrhythmia. Learn more.
-
NEW: Sponsored genetic testing for individuals diagnosed with prostate cancer stage II and above. Learn more.
Follow our progress.
Milestones in our journey to reinvent genetic testing.
Back to full list
Press Releases
Invitae Corporation files registration statement for proposed initial public offering
January 09, 2015
SAN FRANCISCO —January 9, 2015—Invitae Corporation announced today that it has filed a registration statement on Form S‐1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. Invitae intends to apply to list its common stock on The New York Stock Exchange under the symbol “NVTA ...
